Cartesian Therapeutics reports sustained benefits of Descartes-08 CAR-T therapy in generalized myasthenia gravis patients, ...
A congressional commission is calling for at least a $15 billion federal investment in America’s biotechnology sector, ...
The Trump administration will hike payments to Medicare Advantage insurers by more than $25 billion next year, according to ...
PureTech Health, a Boston biopharma company that has created drug developers like Karuna Therapeutics and Seaport ...
The government said it 'may consider future policy options' for anti-obesity medications, after declining to finalize a Biden ...
To make sense of the stock selloff that started late last week, Endpoints News’ Max Bayer and Drew Armstrong spoke to Leerink ...
GSK pays ABL Bio $49.5M upfront for blood-brain barrier platform access, with potential $2.67B in milestone payments. Deal ...
Lexeo reports heart drug data showing improved biomarkers, Spark Therapeutics to cut 298 jobs, and Kashiv BioSciences secures ...
RayThera has collected $110 million in a Series A raise to help it advance a preclinical pipeline of small molecule drugs for ...
Amy Comstock Rick joined the FDA last November, and she not only survived the widespread staff cuts last week, she’s one of only a handful … Get free access to a limited number of articles, ...
A scrappy team of drug developers has come together to create new medicines for patients with autoimmune diseases and allergies. They're going after the bustling subfield of Graves' disease and ...
Multi-partnered ADC startup Duality Biologics is moving forward with its initial public offering plans on the Hong Kong Stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback